Man Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Man Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-473,310	Closed	-$8.31M	–	2211
2021 Q3	$8.31M	Buy	+473,310	New	+$5.53M	0.03%	645

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Man Group's TRIL Position: Q4 2021 in Review

Man Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 473,310 shares — an estimated $8.31M sold.

Man Group first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $8.31M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Man Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Man Group sold 473,310 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $8.31M.
Man Group first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Man Group's Trillium Therapeutics Inc. position peaked at $8.31M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Man Group's 13F filing for Q4 2021, filed 14 Feb 2022.